explore -WSS

explore

author：fashion 2025-09-28 06:09:08 - browse：3335

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Midwives could help bridge maternal health disparities in the U.S.

WSS

Assistant physicians can help address the primary care shortage

Biden calls for immediate release of Niger's president amid apparent coup

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Chamber of Commerce, DOJ clash in court over drug prices

Fed up with FDA, ALS advocates consider a take

White House drug shortage group privately met with industry

leisure time

explore

knowledge

Walensky prepares to leave CDC — and Congress — behind

The unintended consequences of overturning Roe v. Wade

What does generative AI mean for health care? We asked experts

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly CEO gives to Mike Pence presidential super PAC

Jerome Adams on the need for new antivirals for Covid

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Alkermes shareholders re

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

entertainment

Transgender sports debate: Physicians say bans are health issue

Fed up with FDA, ALS advocates consider a take

'A game

What Henrietta Lacks settlement says about racism in medicine

People with substance use disorder deserve online privacy

ER docs worry over extreme heat as a 'mass casualty event'

Wikipedia

hotspot

focus

leisure time